eHealth 2.0 Market Size Was valued at USD 347.5 Bn in 2024 and is predicted to reach USD 851.5 Bn by 2034 at a 9.7% CAGR during the forecast period for 2025-2034.
The term eHealth 2.0 refers to the most recent advancement in digital health. Along with improving the efficiency of healthcare delivery, real-time monitoring, predictive analytics, patient empowerment, and personalized treatment are all given top priority. The characteristics that set eHealth 2.0 apart from earlier digital health strategies are its collaborative and interactive aspects. The increasing need for AI-based medical solutions, digital health records, and remote healthcare services is driving rapid growth in the eHealth 2.0 market. Both the rising cost of healthcare and government initiatives promoting digital healthcare are driving adoption. With the widespread use of mobile devices and internet connectivity, the shift to digital healthcare platforms has been accelerated. More innovation in this field is anticipated to be fueled by emerging technologies like cloud computing, AI, and IoT.
Furthermore, the COVID-19 pandemic significantly increased the use of remote monitoring and telemedicine, leading to increased spending on digital healthcare solutions. eHealth 2.0 is anticipated to play a crucial role in enhancing the efficiency and accessibility of healthcare, particularly in light of the ageing population and growing concerns about chronic diseases. The eHealth 2.0 industry is expected to continue developing steadily in the long run as insurers, pharmaceutical companies, and healthcare providers adopt digital transformation.
Competitive Landscape
Some of the Major Key Players in the eHealth 2.0 Market are
- Boston Scientific Corporation
- Veradigm LLC
- Oracle Cerner
- CVS Health
- Athenahealth Inc.
- American Well
- iCliniq
- Medtronic
- Epocrates
- Medisafe
- IBM
- Doximity, Inc.
- Teladoc Health, Inc.
- LiftLabs
- CompuMed Inc.
- Set Point Medical
- Epic Systems Corporation
- GE Healthcare
- Telecare Corporation
- Optum Health
- Siemens Healthineers
- Veradigm LLC
- eClinicalWorks
- NITEDHEALTH GROUP
- Koninklijke Philips NV
Market Segmentation:
The eHealth 2.0 market is segmented based on service, type, indication, and end-user. Based on service, the market is segmented into monitoring, diagnostic, and treatment. By type, the market is segmented into telemedicine, electronic health records (ehrs), mhealth, e-prescription, remote patient monitoring, health information exchange (hie), and others. By end-user, the market is segmented into healthcare providers, insurers, and others.
Based On The Service, The Monitoring Segment Is Accounted As A Major Contributor To The eHealth 2.0 Market
The monitoring segment is expected to hold a major global market share in 2024. The expansion of this market is anticipated to be driven by the rising demand for self-monitoring devices that automatically track vital signs and a variety of physical activities while building a database. The market has been divided into segments based on services, including health empowerment, diagnostics, and monitoring. Vital signs, specialization, adherence tracking, and accessories are all included in the monitoring sector.
Diagnostic Laboratories Segment To Witness Growth At A Rapid Rate
In healthcare, the two primary e-environments where the concerns of inequality can be described are telemedicine and e-health. Telemedicine is the practice of providing medical care when the patient and the healthcare provider are not in the same physical area. It is a clinical pathway that establishes remote digital interactive connections for clinical diagnostic and therapeutic evaluation. The present e-health and telemedicine practices have brought even more attention to the need for a deeper understanding of how to prevent marginalization and advance fairness.
In The Region, The North American ehealth 2.0 Market Holds A Significant Revenue Share
The North American eHealth 2.0 market is expected to register the highest market share in revenue in the near future. The US's large senior population and the rising prevalence of numerous chronic illnesses have greatly fueled the expansion of the eHealth 2.0 market. Furthermore, the North American eHealth 2.0 industry has been bolstered by rising healthcare spending, greater acceptance of digital technology, and high disposable income. In addition, Asia Pacific is projected to grow rapidly in the global eHealth 2.0 market. The existence of a large number of platforms is favorably influencing the expansion of the market. The need for eHealth 2.0 platforms is being driven by the growing government spending on the creation of advanced, digital healthcare infrastructure. Additionally, the region's eHealth 2.0 market is anticipated to increase due to the quickly increasing senior population and the rising prevalence of various ailments.
Recent Development:
- April 2024: The eHealth Perks rewards program was introduced by eHealth Inc., a private online health insurer. More than 200,000 current eHealth Medicare subscribers have already been enrolled in benefits by the company.
- January 2024: LillyDirect, a revolutionary digital health experience for Americans with diabetes, obesity, and migraines, was introduced by Eli Lilly and Company. Through third-party pharmacy dispensing services, LillyDirect provides illness management tools such as personalized support, direct home delivery of specific Lilly medications, and access to independent healthcare providers.
EHealth 2.0 Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 347.5 Bn |
|
Revenue Forecast In 2034 |
USD 851.5 Bn |
|
Growth Rate CAGR |
CAGR of 9.7% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service, By Type, By Indication, and By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Boston Scientific Corporation, Veradigm LLC, Oracle Cerner, CVS Health, Athenahealth Inc., American Well, iCliniq, Medtronic, Epocrates, Medisafe, IBM, Doximity, Inc., Teladoc Health, Inc., LiftLabs, CompuMed Inc., Set Point Medical, Epic Systems Corporation, GE Healthcare, Telecare Corporation, Optum Health, Siemens Healthineers, eClinicalWorks, UnitedHealth Group, Koninklijke Philips NV, and other. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
